All Pharma News
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors

89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
GLOBENEWSWIRE
17 Apr 2024
Share Share
89bio lines up BiBo Pharma to build $135M commercial API plant

89bio lines up BiBo Pharma to build $135M commercial API plant
Kevin Dunleavy FIERCE PHARMA
11 Apr 2024
Share Share
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GLOBENEWSWIRE
05 Apr 2024
Share Share
89bio Receives EMA Status for Pegozafermin in the Treatment of MASH

89bio Receives EMA Status for Pegozafermin in the Treatment of MASH
GLOBENEWSWIRE
27 Mar 2024
Share Share
89bio wins EMA priority status for MASH candidate pegozafermin

89bio wins EMA priority status for MASH candidate pegozafermin
Robert Barrie PHARMACEUTICAL TECHNOLOGY
27 Mar 2024
Share Share
89bio Initiates Phase 3 ENLIGHTEN-Fibrosis Trial of Pegozafermin

89bio Initiates Phase 3 ENLIGHTEN-Fibrosis Trial of Pegozafermin
GLOBENEWSWIRE
12 Mar 2024
Share Share
89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GLOBENEWSWIRE
08 Mar 2024
Share Share
89bio to Participate in the Leerink Partners Global Biopharma Conference

89bio to Participate in the Leerink Partners Global Biopharma Conference
GLOBENEWSWIRE
05 Mar 2024
Share Share
89bio Reports Fourth Quarter and Full Year 2023 Financial Results

89bio Reports Fourth Quarter and Full Year 2023 Financial Results
GLOBENEWSWIRE
29 Feb 2024
Share Share
89bio to Participate in the Oppenheimer 34th Annual Life Sciences Conference

89bio to Participate in the Oppenheimer 34th Annual Life Sciences Conference
GLOBENEWSWIRE
06 Feb 2024
Share Share